Affordable Access

In vivo activation of the cystic fibrosis transmembrane conductance regulator mutant ΔF508 in murine nasal epithelium

Authors
  • Thomas J. Kelley
  • Kirk Thomas
  • Laura J. H. Milgram
  • Mitchell L. Drumm
Publisher
The National Academy of Sciences of the USA
Publication Date
Mar 18, 1997
Source
PMC
Keywords
Disciplines
  • Biology
  • Medicine
  • Pharmacology
License
Unknown

Abstract

The gene causing cystic fibrosis (CF) encodes the CF transmembrane conductance regulator (CFTR), a cAMP-regulated chloride channel. Mutations in this gene result in reduced transepithelial chloride permeability across tissues affected in CF. Consequently, restoring chloride permeability to these tissues may prove therapeutic. Here we report that a combination of forskolin, an adenylate cyclase activator, and milrinone, an inhibitor of class III phosphodiesterases, increases the magnitude of the potential difference across nasal epithelium of mice homozygous for the most common CF mutation, ΔF508, while neither drug alone has a significant effect on potential difference. Transgenic mice lacking CFTR do not respond to the milrinone/forskolin combination, indicating that the effect in ΔF508 mice requires CFTR. These results suggest that, by pharmacological means, at least partial CFTR-mediated electrolyte transport can be restored in vivo to CF tissues expressing ΔF508.

Report this publication

Statistics

Seen <100 times